Validation of Texture Changing Coatings for Use in At-Home Rapid Tests
Part of paid clinical trials in Newark, Delaware.
- Sponsor
- University of Delaware
- Study ID
- NCT06539728
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Blindness
- Vision, Low
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Interaction with Mock COVID-19 Rapid Antigen Test and Reference Surfaces — DIAGNOSTIC_TESTParticipants will drop a saline solution with proteins onto the testing device. They will wait for it to dry and then report on the tactile sensation and overall feel of the surface. Feedback will include comparisons with the two reference surfaces. The primary goal is to determine the presence of mock COVID antigen in synthetic saliva using the device, which aligns with the goals of diagnostic testing.
- Biomechanical Measurements — DIAGNOSTIC_TESTParticipants may have biomechanical measurements recorded, such as placing samples on a scale to measure downward force or using medical tape with a flexible wire to track finger motion. These measurements are likely aimed at objectively assessing how participants interact with the surfaces and their physical responses to tactile stimuli.
- Psychophysical Tasks — BEHAVIORALParticipants may alternatively be asked to perform standardized psychophysical tasks, such as Two Alternative Forced Choice tests, Odd-Man Out tests, or Magnitude Estimation tests. These tasks will provide structured comparisons and quantitative data on participants' perception and preferences regarding tactile qualities. The tasks are designed to evaluate participants' perception and preferences regarding tactile qualities, which involves behavioral responses to sensory stimuli.
Study Details
At-home testing is an important part of mitigating the spread of COVID-19, but these tests are not accessible to people with low vision or blindness. Instead of adapting to a technology originally built for sighted people, investigators propose a no-power version that reports test results through a texture change, which people can feel by touch. This platform could be used not only for COVID, but also for other diagnostics, and will promote the independence and privacy for people with low vision or blindness by removing the need for human assistance or an internet connection.
Key Dates
- Start date
- Jun 30, 2025
- Status verified
- Jun 2024
- Primary completion
- Aug 31, 2025
- Completion
- Aug 31, 2025
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Interaction with Coated SurfacesParticipants in this arm will interact with the device and surface coated with the polymer-antibody coating. Subjects will be trained with a "positive" test and "negative" test prior to device testing. Subjects will then administer the synthetic saliva themselves and asked to determine if there was COVID antigen in the saliva by touching the device to compare the test patch to the positive and negative control patches. Subjects will also rate device usability.
Primary Outcome Measure
Success rate of identifying whether the model test is positive or negative [ Time Frame: Through study completion, an average of 1 year ]
Central Contacts
- Charles Dhong, PhD302-831-2828
- Cynthia Papettas302-279-6766
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Delaware | Newark | Delaware | 19711 | Charles Dhong, PhD |
Find similar trials in Newark, DE
Related Studies
- Testing Tactile Aids With Blind SubjectsRecruiting · University of Delaware · Newark, Delaware
- Stem Cell Ophthalmology Treatment Study IIRecruiting · MD Stem Cells · Westport, Connecticut
- Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)PHASE3 · Recruiting · Laboratoires Thea · San Francisco, California
- Evaluating Stairway Designs for Individuals With Vision ImpairmentRecruiting · The University of Alabama in Huntsville · Huntsville, Alabama